Eye Care Supplement MarketThe global eye care supplement market is on the cusp of significant expansion, with leading market analysis authority Future Market Insights (FMI) predicting a valuation of ...

In the phase 3b STEP UP study, an experimental 7.2-mg semaglutide dose helped patients lose more weight on average at 72 weeks compared to placebo or semaglutide 2.4 mg, which is currently the ...

Nintendo revealed the Switch 2 via a several-minute-long YouTube trailer that showed off the new console's contours and a single Mario Kart game but little else. The Switch 2 was rumored for a ...

Nintendo has officially revealed the Switch 2, its successor to the wildly popular Switch console. Like the original Switch, the Switch 2 is a hybrid home and handheld gaming console, but with ...

He joined The Verge in 2019 after nearly two years at Techmeme. Nintendo shared the first details about the Nintendo Switch 2 in a video published Thursday. Nintendo doesn’t give a specific ...

The Switch 2 has been revealed, and it's coming this year. But Nintendo's not telling us more until April 2. For now, here's the trailer: Yes, there's a new Mario Kart. And yes, this looks a lot ...

Nintendo has finally revealed the Switch 2 with a video that confirms a number of new features while sparking burning questions for fans to discuss. While pre-announce leaks proved to be pretty ...

COPENHAGEN, Denmark, January 15, 2025 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, has now completed ...

Nintendo has finally lifted the curtain on its next console. Officially named the Nintendo Switch 2, the long-awaited Nintendo Switch successor is officially set to launch in 2025. Here's the most ...

The Nintendo Switch 2 has been confirmed, and we'll find out more about it in a Nintendo Direct focused on the new console that's coming in early April. In a video released a few minutes ago ...

has now completed the dosing of all 16 patients in its phase 2 trial with the company’s lead asset EVX-01. Designed with Evaxion’s AI-Immunology™ platform, EVX-01 is a personalized cancer ...

Miller, MD, chair of ophthalmology at Mass Eye and Ear, discusses the role of AREDS vitamins in slowing ... and anatomical changes from the phase 2 ARCHER trial. Presented at: American Academy ...